nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—PRKD1—smooth muscle tissue—jejunal cancer	0.0127	0.0127	CbGeAlD
Crizotinib—PRKD3—pancreas—jejunal cancer	0.0113	0.0113	CbGeAlD
Crizotinib—NEK9—lymphoid tissue—jejunal cancer	0.0111	0.0111	CbGeAlD
Crizotinib—MAPK7—pancreas—jejunal cancer	0.0104	0.0104	CbGeAlD
Crizotinib—MET—pancreas—jejunal cancer	0.00974	0.00974	CbGeAlD
Crizotinib—BLK—lymphoid tissue—jejunal cancer	0.00939	0.00939	CbGeAlD
Crizotinib—NEK9—endocrine gland—jejunal cancer	0.00907	0.00907	CbGeAlD
Crizotinib—ACVR1B—pancreas—jejunal cancer	0.009	0.009	CbGeAlD
Crizotinib—MAPK7—lymphoid tissue—jejunal cancer	0.009	0.009	CbGeAlD
Crizotinib—TXK—lymphoid tissue—jejunal cancer	0.009	0.009	CbGeAlD
Crizotinib—IKBKE—lymph node—jejunal cancer	0.00875	0.00875	CbGeAlD
Crizotinib—MET—lymphoid tissue—jejunal cancer	0.00842	0.00842	CbGeAlD
Crizotinib—IGF1R—smooth muscle tissue—jejunal cancer	0.00828	0.00828	CbGeAlD
Crizotinib—PRKD1—endocrine gland—jejunal cancer	0.00827	0.00827	CbGeAlD
Crizotinib—SIK2—endocrine gland—jejunal cancer	0.00815	0.00815	CbGeAlD
Crizotinib—CDK7—lymphoid tissue—jejunal cancer	0.00814	0.00814	CbGeAlD
Crizotinib—TIE1—smooth muscle tissue—jejunal cancer	0.00805	0.00805	CbGeAlD
Crizotinib—PRKD3—endocrine gland—jejunal cancer	0.00795	0.00795	CbGeAlD
Crizotinib—IGF1R—pancreas—jejunal cancer	0.00765	0.00765	CbGeAlD
Crizotinib—JAK3—lymphoid tissue—jejunal cancer	0.00743	0.00743	CbGeAlD
Crizotinib—MAPK7—endocrine gland—jejunal cancer	0.00734	0.00734	CbGeAlD
Crizotinib—TXK—endocrine gland—jejunal cancer	0.00734	0.00734	CbGeAlD
Crizotinib—PLK4—lymphoid tissue—jejunal cancer	0.00733	0.00733	CbGeAlD
Crizotinib—STK4—lymphoid tissue—jejunal cancer	0.00729	0.00729	CbGeAlD
Crizotinib—TYRO3—lymphoid tissue—jejunal cancer	0.00689	0.00689	CbGeAlD
Crizotinib—FER—lymphoid tissue—jejunal cancer	0.00689	0.00689	CbGeAlD
Crizotinib—ALK—lymphoid tissue—jejunal cancer	0.00689	0.00689	CbGeAlD
Crizotinib—MET—endocrine gland—jejunal cancer	0.00687	0.00687	CbGeAlD
Crizotinib—LYN—lymphoid tissue—jejunal cancer	0.00685	0.00685	CbGeAlD
Crizotinib—NUAK2—pancreas—jejunal cancer	0.00682	0.00682	CbGeAlD
Crizotinib—ACVR1—pancreas—jejunal cancer	0.00677	0.00677	CbGeAlD
Crizotinib—MAP4K1—lymphoid tissue—jejunal cancer	0.00675	0.00675	CbGeAlD
Crizotinib—PTK2B—smooth muscle tissue—jejunal cancer	0.00667	0.00667	CbGeAlD
Crizotinib—CDK7—endocrine gland—jejunal cancer	0.00665	0.00665	CbGeAlD
Crizotinib—STK35—pancreas—jejunal cancer	0.00664	0.00664	CbGeAlD
Crizotinib—IGF1R—lymphoid tissue—jejunal cancer	0.00662	0.00662	CbGeAlD
Crizotinib—MAP4K2—lymphoid tissue—jejunal cancer	0.00653	0.00653	CbGeAlD
Crizotinib—ACVR1B—endocrine gland—jejunal cancer	0.00635	0.00635	CbGeAlD
Crizotinib—AURKA—lymphoid tissue—jejunal cancer	0.00627	0.00627	CbGeAlD
Crizotinib—NEK9—lymph node—jejunal cancer	0.00627	0.00627	CbGeAlD
Crizotinib—PTK2—smooth muscle tissue—jejunal cancer	0.00615	0.00615	CbGeAlD
Crizotinib—TYK2—smooth muscle tissue—jejunal cancer	0.0061	0.0061	CbGeAlD
Crizotinib—JAK3—endocrine gland—jejunal cancer	0.00606	0.00606	CbGeAlD
Crizotinib—EPHA6—endocrine gland—jejunal cancer	0.00606	0.00606	CbGeAlD
Crizotinib—MERTK—lymphoid tissue—jejunal cancer	0.00605	0.00605	CbGeAlD
Crizotinib—IRAK1—smooth muscle tissue—jejunal cancer	0.00602	0.00602	CbGeAlD
Crizotinib—DCLK1—endocrine gland—jejunal cancer	0.00602	0.00602	CbGeAlD
Crizotinib—PLK4—endocrine gland—jejunal cancer	0.00599	0.00599	CbGeAlD
Crizotinib—STK4—endocrine gland—jejunal cancer	0.00595	0.00595	CbGeAlD
Crizotinib—LIMK2—lymphoid tissue—jejunal cancer	0.00592	0.00592	CbGeAlD
Crizotinib—RPS6KB1—smooth muscle tissue—jejunal cancer	0.00591	0.00591	CbGeAlD
Crizotinib—FLT3—lymphoid tissue—jejunal cancer	0.00586	0.00586	CbGeAlD
Crizotinib—AXL—smooth muscle tissue—jejunal cancer	0.00585	0.00585	CbGeAlD
Crizotinib—PRKD1—lymph node—jejunal cancer	0.00571	0.00571	CbGeAlD
Crizotinib—TBK1—pancreas—jejunal cancer	0.00568	0.00568	CbGeAlD
Crizotinib—PTK2—pancreas—jejunal cancer	0.00568	0.00568	CbGeAlD
Crizotinib—TYK2—pancreas—jejunal cancer	0.00564	0.00564	CbGeAlD
Crizotinib—LIMK1—lymph node—jejunal cancer	0.00564	0.00564	CbGeAlD
Crizotinib—FER—endocrine gland—jejunal cancer	0.00562	0.00562	CbGeAlD
Crizotinib—EPHA5—endocrine gland—jejunal cancer	0.00562	0.00562	CbGeAlD
Crizotinib—ALK—endocrine gland—jejunal cancer	0.00562	0.00562	CbGeAlD
Crizotinib—TYRO3—endocrine gland—jejunal cancer	0.00562	0.00562	CbGeAlD
Crizotinib—LYN—endocrine gland—jejunal cancer	0.00559	0.00559	CbGeAlD
Crizotinib—EPHB4—smooth muscle tissue—jejunal cancer	0.00559	0.00559	CbGeAlD
Crizotinib—IRAK1—pancreas—jejunal cancer	0.00557	0.00557	CbGeAlD
Crizotinib—TNK1—endocrine gland—jejunal cancer	0.00556	0.00556	CbGeAlD
Crizotinib—JAK2—smooth muscle tissue—jejunal cancer	0.00555	0.00555	CbGeAlD
Crizotinib—BMPR1B—endocrine gland—jejunal cancer	0.00551	0.00551	CbGeAlD
Crizotinib—PRKD3—lymph node—jejunal cancer	0.00549	0.00549	CbGeAlD
Crizotinib—RPS6KB1—pancreas—jejunal cancer	0.00547	0.00547	CbGeAlD
Crizotinib—TNK2—endocrine gland—jejunal cancer	0.0054	0.0054	CbGeAlD
Crizotinib—IGF1R—endocrine gland—jejunal cancer	0.0054	0.0054	CbGeAlD
Crizotinib—DSTYK—lymph node—jejunal cancer	0.00536	0.00536	CbGeAlD
Crizotinib—TEK—smooth muscle tissue—jejunal cancer	0.00535	0.00535	CbGeAlD
Crizotinib—MAP4K5—smooth muscle tissue—jejunal cancer	0.00535	0.00535	CbGeAlD
Crizotinib—PTK2B—lymphoid tissue—jejunal cancer	0.00533	0.00533	CbGeAlD
Crizotinib—MAP4K2—endocrine gland—jejunal cancer	0.00533	0.00533	CbGeAlD
Crizotinib—BLK—lymph node—jejunal cancer	0.0053	0.0053	CbGeAlD
Crizotinib—LTK—lymph node—jejunal cancer	0.00524	0.00524	CbGeAlD
Crizotinib—CASK—lymph node—jejunal cancer	0.00524	0.00524	CbGeAlD
Crizotinib—SLK—pancreas—jejunal cancer	0.00521	0.00521	CbGeAlD
Crizotinib—EPHB4—pancreas—jejunal cancer	0.00517	0.00517	CbGeAlD
Crizotinib—AURKA—endocrine gland—jejunal cancer	0.00512	0.00512	CbGeAlD
Crizotinib—TESK1—endocrine gland—jejunal cancer	0.00508	0.00508	CbGeAlD
Crizotinib—MAPK7—lymph node—jejunal cancer	0.00508	0.00508	CbGeAlD
Crizotinib—TXK—lymph node—jejunal cancer	0.00508	0.00508	CbGeAlD
Crizotinib—EPHA2—pancreas—jejunal cancer	0.00507	0.00507	CbGeAlD
Crizotinib—FES—lymph node—jejunal cancer	0.00502	0.00502	CbGeAlD
Crizotinib—MAP3K2—lymphoid tissue—jejunal cancer	0.00502	0.00502	CbGeAlD
Crizotinib—MAP4K5—pancreas—jejunal cancer	0.00495	0.00495	CbGeAlD
Crizotinib—TEK—pancreas—jejunal cancer	0.00495	0.00495	CbGeAlD
Crizotinib—YES1—smooth muscle tissue—jejunal cancer	0.00494	0.00494	CbGeAlD
Crizotinib—MERTK—endocrine gland—jejunal cancer	0.00494	0.00494	CbGeAlD
Crizotinib—TBK1—lymphoid tissue—jejunal cancer	0.00491	0.00491	CbGeAlD
Crizotinib—PTK2—lymphoid tissue—jejunal cancer	0.00491	0.00491	CbGeAlD
Crizotinib—TYK2—lymphoid tissue—jejunal cancer	0.00488	0.00488	CbGeAlD
Crizotinib—LIMK2—endocrine gland—jejunal cancer	0.00483	0.00483	CbGeAlD
Crizotinib—MAP3K12—endocrine gland—jejunal cancer	0.00478	0.00478	CbGeAlD
Crizotinib—FLT3—endocrine gland—jejunal cancer	0.00478	0.00478	CbGeAlD
Crizotinib—ACVR1—endocrine gland—jejunal cancer	0.00478	0.00478	CbGeAlD
Crizotinib—SRC—smooth muscle tissue—jejunal cancer	0.00476	0.00476	CbGeAlD
Crizotinib—MET—lymph node—jejunal cancer	0.00475	0.00475	CbGeAlD
Crizotinib—RPS6KB1—lymphoid tissue—jejunal cancer	0.00473	0.00473	CbGeAlD
Crizotinib—FGR—lymphoid tissue—jejunal cancer	0.0047	0.0047	CbGeAlD
Crizotinib—STK35—endocrine gland—jejunal cancer	0.00468	0.00468	CbGeAlD
Crizotinib—AXL—lymphoid tissue—jejunal cancer	0.00468	0.00468	CbGeAlD
Crizotinib—CDK7—lymph node—jejunal cancer	0.0046	0.0046	CbGeAlD
Crizotinib—YES1—pancreas—jejunal cancer	0.00457	0.00457	CbGeAlD
Crizotinib—TAOK2—lymph node—jejunal cancer	0.00456	0.00456	CbGeAlD
Crizotinib—TAOK3—pancreas—jejunal cancer	0.00451	0.00451	CbGeAlD
Crizotinib—BMP2K—endocrine gland—jejunal cancer	0.00451	0.00451	CbGeAlD
Crizotinib—JAK2—lymphoid tissue—jejunal cancer	0.00444	0.00444	CbGeAlD
Crizotinib—SRC—pancreas—jejunal cancer	0.0044	0.0044	CbGeAlD
Crizotinib—EPHA3—lymph node—jejunal cancer	0.00439	0.00439	CbGeAlD
Crizotinib—ACVR1B—lymph node—jejunal cancer	0.00439	0.00439	CbGeAlD
Crizotinib—EPHA2—lymphoid tissue—jejunal cancer	0.00439	0.00439	CbGeAlD
Crizotinib—PTK2B—endocrine gland—jejunal cancer	0.00435	0.00435	CbGeAlD
Crizotinib—RIPK2—endocrine gland—jejunal cancer	0.00432	0.00432	CbGeAlD
Crizotinib—TEK—lymphoid tissue—jejunal cancer	0.00428	0.00428	CbGeAlD
Crizotinib—MAP4K5—lymphoid tissue—jejunal cancer	0.00428	0.00428	CbGeAlD
Crizotinib—CSF1R—smooth muscle tissue—jejunal cancer	0.00427	0.00427	CbGeAlD
Crizotinib—JAK3—lymph node—jejunal cancer	0.00419	0.00419	CbGeAlD
Crizotinib—EPHA4—endocrine gland—jejunal cancer	0.00417	0.00417	CbGeAlD
Crizotinib—DCLK1—lymph node—jejunal cancer	0.00416	0.00416	CbGeAlD
Crizotinib—PLK4—lymph node—jejunal cancer	0.00414	0.00414	CbGeAlD
Crizotinib—STK4—lymph node—jejunal cancer	0.00411	0.00411	CbGeAlD
Crizotinib—MAP3K2—endocrine gland—jejunal cancer	0.00409	0.00409	CbGeAlD
Crizotinib—TBK1—endocrine gland—jejunal cancer	0.00401	0.00401	CbGeAlD
Crizotinib—PTK2—endocrine gland—jejunal cancer	0.00401	0.00401	CbGeAlD
Crizotinib—TYK2—endocrine gland—jejunal cancer	0.00398	0.00398	CbGeAlD
Crizotinib—YES1—lymphoid tissue—jejunal cancer	0.00395	0.00395	CbGeAlD
Crizotinib—STK10—lymphoid tissue—jejunal cancer	0.00392	0.00392	CbGeAlD
Crizotinib—TAOK3—lymphoid tissue—jejunal cancer	0.0039	0.0039	CbGeAlD
Crizotinib—FER—lymph node—jejunal cancer	0.00389	0.00389	CbGeAlD
Crizotinib—ALK—lymph node—jejunal cancer	0.00389	0.00389	CbGeAlD
Crizotinib—RPS6KB1—endocrine gland—jejunal cancer	0.00386	0.00386	CbGeAlD
Crizotinib—TNK1—lymph node—jejunal cancer	0.00385	0.00385	CbGeAlD
Crizotinib—FGR—endocrine gland—jejunal cancer	0.00383	0.00383	CbGeAlD
Crizotinib—AXL—endocrine gland—jejunal cancer	0.00382	0.00382	CbGeAlD
Crizotinib—BMPR1B—lymph node—jejunal cancer	0.00381	0.00381	CbGeAlD
Crizotinib—MAP4K1—lymph node—jejunal cancer	0.00381	0.00381	CbGeAlD
Crizotinib—SRC—lymphoid tissue—jejunal cancer	0.0038	0.0038	CbGeAlD
Crizotinib—TNK2—lymph node—jejunal cancer	0.00373	0.00373	CbGeAlD
Crizotinib—IGF1R—lymph node—jejunal cancer	0.00373	0.00373	CbGeAlD
Crizotinib—MAP4K2—lymph node—jejunal cancer	0.00368	0.00368	CbGeAlD
Crizotinib—EPHB4—endocrine gland—jejunal cancer	0.00365	0.00365	CbGeAlD
Crizotinib—STK3—lymph node—jejunal cancer	0.00363	0.00363	CbGeAlD
Crizotinib—TIE1—lymph node—jejunal cancer	0.00363	0.00363	CbGeAlD
Crizotinib—JAK2—endocrine gland—jejunal cancer	0.00362	0.00362	CbGeAlD
Crizotinib—EPHA2—endocrine gland—jejunal cancer	0.00358	0.00358	CbGeAlD
Crizotinib—AURKA—lymph node—jejunal cancer	0.00354	0.00354	CbGeAlD
Crizotinib—TESK1—lymph node—jejunal cancer	0.00351	0.00351	CbGeAlD
Crizotinib—MAP4K5—endocrine gland—jejunal cancer	0.00349	0.00349	CbGeAlD
Crizotinib—TEK—endocrine gland—jejunal cancer	0.00349	0.00349	CbGeAlD
Crizotinib—MAP3K3—endocrine gland—jejunal cancer	0.00349	0.00349	CbGeAlD
Crizotinib—MERTK—lymph node—jejunal cancer	0.00342	0.00342	CbGeAlD
Crizotinib—CSF1R—lymphoid tissue—jejunal cancer	0.00341	0.00341	CbGeAlD
Crizotinib—ABL1—smooth muscle tissue—jejunal cancer	0.00337	0.00337	CbGeAlD
Crizotinib—LIMK2—lymph node—jejunal cancer	0.00334	0.00334	CbGeAlD
Crizotinib—NUAK2—lymph node—jejunal cancer	0.00333	0.00333	CbGeAlD
Crizotinib—ACVR1—lymph node—jejunal cancer	0.0033	0.0033	CbGeAlD
Crizotinib—MAP3K12—lymph node—jejunal cancer	0.0033	0.0033	CbGeAlD
Crizotinib—FLT3—lymph node—jejunal cancer	0.0033	0.0033	CbGeAlD
Crizotinib—STK35—lymph node—jejunal cancer	0.00324	0.00324	CbGeAlD
Crizotinib—YES1—endocrine gland—jejunal cancer	0.00322	0.00322	CbGeAlD
Crizotinib—STK10—endocrine gland—jejunal cancer	0.0032	0.0032	CbGeAlD
Crizotinib—TAOK3—endocrine gland—jejunal cancer	0.00318	0.00318	CbGeAlD
Crizotinib—ABL2—lymph node—jejunal cancer	0.00316	0.00316	CbGeAlD
Crizotinib—ABL1—pancreas—jejunal cancer	0.00312	0.00312	CbGeAlD
Crizotinib—BMP2K—lymph node—jejunal cancer	0.00312	0.00312	CbGeAlD
Crizotinib—SRC—endocrine gland—jejunal cancer	0.0031	0.0031	CbGeAlD
Crizotinib—PTK2B—lymph node—jejunal cancer	0.00301	0.00301	CbGeAlD
Crizotinib—RIPK2—lymph node—jejunal cancer	0.00299	0.00299	CbGeAlD
Crizotinib—EPHA4—lymph node—jejunal cancer	0.00289	0.00289	CbGeAlD
Crizotinib—MAP3K2—lymph node—jejunal cancer	0.00283	0.00283	CbGeAlD
Crizotinib—CSF1R—endocrine gland—jejunal cancer	0.00279	0.00279	CbGeAlD
Crizotinib—TBK1—lymph node—jejunal cancer	0.00277	0.00277	CbGeAlD
Crizotinib—PTK2—lymph node—jejunal cancer	0.00277	0.00277	CbGeAlD
Crizotinib—TYK2—lymph node—jejunal cancer	0.00275	0.00275	CbGeAlD
Crizotinib—IRAK1—lymph node—jejunal cancer	0.00272	0.00272	CbGeAlD
Crizotinib—ABL1—lymphoid tissue—jejunal cancer	0.0027	0.0027	CbGeAlD
Crizotinib—RPS6KB1—lymph node—jejunal cancer	0.00267	0.00267	CbGeAlD
Crizotinib—LCK—lymph node—jejunal cancer	0.00265	0.00265	CbGeAlD
Crizotinib—FGR—lymph node—jejunal cancer	0.00265	0.00265	CbGeAlD
Crizotinib—AXL—lymph node—jejunal cancer	0.00264	0.00264	CbGeAlD
Crizotinib—SLK—lymph node—jejunal cancer	0.00254	0.00254	CbGeAlD
Crizotinib—EPHB4—lymph node—jejunal cancer	0.00252	0.00252	CbGeAlD
Crizotinib—JAK2—lymph node—jejunal cancer	0.0025	0.0025	CbGeAlD
Crizotinib—EPHA2—lymph node—jejunal cancer	0.00247	0.00247	CbGeAlD
Crizotinib—MAP3K3—lymph node—jejunal cancer	0.00241	0.00241	CbGeAlD
Crizotinib—TEK—lymph node—jejunal cancer	0.00241	0.00241	CbGeAlD
Crizotinib—MAP4K5—lymph node—jejunal cancer	0.00241	0.00241	CbGeAlD
Crizotinib—EPHB6—lymph node—jejunal cancer	0.00231	0.00231	CbGeAlD
Crizotinib—YES1—lymph node—jejunal cancer	0.00223	0.00223	CbGeAlD
Crizotinib—STK10—lymph node—jejunal cancer	0.00221	0.00221	CbGeAlD
Crizotinib—ABL1—endocrine gland—jejunal cancer	0.0022	0.0022	CbGeAlD
Crizotinib—TAOK3—lymph node—jejunal cancer	0.0022	0.0022	CbGeAlD
Crizotinib—SRC—lymph node—jejunal cancer	0.00214	0.00214	CbGeAlD
Crizotinib—CSF1R—lymph node—jejunal cancer	0.00193	0.00193	CbGeAlD
Crizotinib—CYP3A5—pancreas—jejunal cancer	0.00183	0.00183	CbGeAlD
Crizotinib—ABL1—lymph node—jejunal cancer	0.00152	0.00152	CbGeAlD
Crizotinib—CYP3A5—endocrine gland—jejunal cancer	0.00129	0.00129	CbGeAlD
Crizotinib—ABCB1—pancreas—jejunal cancer	0.00097	0.00097	CbGeAlD
Crizotinib—CYP3A4—endocrine gland—jejunal cancer	0.000967	0.000967	CbGeAlD
Crizotinib—ABCB1—lymphoid tissue—jejunal cancer	0.000839	0.000839	CbGeAlD
Crizotinib—ABCB1—endocrine gland—jejunal cancer	0.000685	0.000685	CbGeAlD
Crizotinib—ABCB1—lymph node—jejunal cancer	0.000473	0.000473	CbGeAlD
